Clinical Trials Browser

Completed × Borderline Resectable Pancreatic Adenocarcinoma × Irinotecan × Clear all

NCT03970252 2024-08-09

Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer

Phase EARLY_PHASE1 Completed

Gastrointestinal

Borderline Resectable Pancreatic Adenocarcinoma